PCSK9 Inhibitors: Heralding A New Era In Dyslipidemia Management
Journal Title: BMH Medical Journal - Year 2019, Vol 6, Issue 4
Abstract
Dyslipidemia is a well known risk factor for cardiovascular disease. Till now statins were the sheet anchor of therapy for dyslipidemia. But there are a few patients who are intolerant to statins and some who develop cardiovascular disease in spite of maximally tolerated dose of statins. Still there are some others like those with familial hypercholesterolemia who do not achieve adequate reduction of cholesterol levels with statins alone or in combination with ezetimibe. Now we have a new group of medications - proprotein convertase subtilsin-kexin type 9 (PCSK9) inhibitors, to cater to these group of patients.
Authors and Affiliations
Johnson Francis
Keywords
Related Articles
- EP ID EP648141
- DOI -
- Views 122
- Downloads 0
Rhabdomyolysis Due To Hashimoto’s Thyroiditis Aggravated By Asthma Exacerbation
Hashimoto's thyroiditis is the most common form of primary hypothyroidism. Patients may present with muscular manifestations like weakness, stiffness, pain and elevated muscle enzymes. Rhabdomyolysis has been reported in...
A Rare Case Of Acute Lupus Nephritis In Pregnancy
Systemic lupus nephritis is an autoimmune connective tissue disorder that commonly affects women in the reproductive age group. 80% of women with systemic lupus erythematosis develop lupus nehritis. Pregnancy in any clas...
Digoxin Dilemma
Digoxin is a very commonly used drug in patients with systolic heart failure for enhancing cardiac contractility and in patients with supraventricular tachyarrhythmias for ventricular rate control. Due to its varied pres...
Robotic Telesurgery: Benefits Beyond Barriers
The idea of robotic telesurgery dates back to the 1970s when the National Aeronautics and Space Administration (NASA) developed a project to utilize remotely controlled robots to perform surgeries on astronauts. The hist...
Hypersensitivity Pneumonitis Due To Domestic Mold
Hypersensitivity pneumonitis (HP) is a syndrome caused by repeated inhalation of specific antigens from environmental exposure in sensitized individuals. It is considered a granulomatous interstitial disease of the lungs...